Oxyntomodulin, a gut-derived peptide hormone, activates both the GLP-1R and the GCGR, although, with reduced affinity compared to GLP-1 and glucagon, respectively
In subjects with T2DM, weekly administration of tirzepatide at doses of 5 mg, 10 mg, or 15 mg was associated with greater weight loss compared to placebo ( 6.3 kg, 8.4 kg, and 9.4 kg, respectively), and 1.7 kg, 4.8 kg, and 7.2 kg greater weight loss compared to selective GLP-1 receptor agonists, demonstrating a dose-dependent effect sustained for up to 2 years [48]
The approval of this oral version opens up new possibilities for patients who prefer a non-injectable method of weight management, offering them a scientifically-backed tool for achieving sustainable weight loss and better metabolic health under medical supervision What Is Oral Semaglutide and How Does It Work for Weight Loss
Nootropics, or smart drugs, are a group of supplements that claim to support memory, learning, and focuskind of like a less intense version of the pill from the 2011 film Limitless
The Medicare GLP-1 Bridge program launching in July 2026 will provide access to Wegovy, Zepbound, and Foundayo at just $50 per month for eligible beneficiaries through the end of 2027, with the BALANCE Model providing a long-term path for continued Part D coverage beyond that
